Bacterial growth in respiratory tract

Bacterial growth in the respiratory tract encompasses both **commensal and pathogenic bacteria's ability to colonize and proliferate** within the upper and lower airways[3][1][9]. The process may result in benign colonization, contribute to host immune regulation, or lead to acute and chronic infection such as pneumonia, sinusitis, and exacerbations of chronic diseases[2][4][8]. Pathogenic bacteria access nutrients, form biofilms, and evade immune defenses, sometimes in cooperation or competition with other microbes[1][5]. Antibiotic therapy is guided empirically based on the likely pathogens and patient risk factors, but antimicrobial stewardship and novel delivery approaches are increasingly important due to resistance and limited access of drugs to sites of infection[2][6]. "Bacterial growth in respiratory tract" is thus a clinical and microbiological phenomenon, not a discrete molecular therapeutic target.

Other names

Bacterial colonization of respiratory tractBacterial respiratory infectionRespiratory tract bacterial burden

Inhibition of bacterial cell wall synthesis (beta-lactams)[4][6] - Inhibition of protein synthesis (macrolides, tetracyclines, pleuromutilins)[6] - Inhibition of DNA gyrase and topoisomerase IV (fluoroquinolones)[6]